Publication: Suppression of erythroid development in vitro by Plasmodium vivax
Submitted Date
Received Date
Accepted Date
Issued Date
2012-05-25
Copyright Date
Announcement No.
Application No.
Patent No.
Valid Date
Resource Type
Edition
Resource Version
Language
File Type
No. of Pages/File Size
ISBN
ISSN
14752875
eISSN
Scopus ID
WOS ID
Pubmed ID
arXiv ID
Call No.
Other identifier(s)
2-s2.0-84861337604
Journal Title
Volume
Issue
item.page.oaire.edition
Start Page
End Page
Access Rights
Access Status
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Physical Location
Bibliographic Citation
Malaria Journal. Vol.11, (2012)
Citation
Tasanee Panichakul, Witchuda Payuhakrit, Panyu Panburana, Chokdee Wongborisuth, Suradej Hongeng, Rachanee Udomsangpetch (2012). Suppression of erythroid development in vitro by Plasmodium vivax. Retrieved from: https://repository.li.mahidol.ac.th/handle/123456789/14319.
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
Suppression of erythroid development in vitro by Plasmodium vivax
Alternative Title(s)
Author's Affiliation
Author's E-mail
Editor(s)
Editor's Affiliation
Corresponding Author(s)
Creator(s)
Compiler
Advisor(s)
Illustrator(s)
Applicant(s)
Inventor(s)
Issuer
Assignee
Other Contributor(s)
Series
Has Part
Abstract
Background: Severe anaemia due to dyserythropoiesis has been documented in patients infected with Plasmodium vivax, however the mechanism responsible for anaemia in vivax malaria is poorly understood. In order to better understand the role of P. vivax infection in anaemia the inhibition of erythropoiesis using haematopoietic stem cells was investigated. Methods: Haematopoietic stem cells/CD34 + cells, isolated from normal human cord blood were used to generate growing erythroid cells. Exposure of CD34 + cells and growing erythroid cells to P. vivax parasites either from intact or lysed infected erythrocytes (IE) was examined for the effect on inhibition of cell development compared with untreated controls. Results: Both lysed and intact infected erythrocytes significantly inhibited erythroid growth. The reduction of erythro id growth did not differ significantly between exposure to intact and lysed IE and the mean growth relative to unexposed controls was 59.4 ± 5.2 for lysed IE and 57 ± 8.5% for intact IE. Interestingly, CD34 + cells/erythroid progenitor cells were susceptible to the inhibitory effect of P. vivax on cell expansion. Exposure to P. vivax also inhibited erythroid development, as determined by the reduced expression of glycophorin A (28.1%) and CD 71 (43.9%). Moreover, vivax parasites perturbed the division of erythroid cells, as measured by the Cytokinesis Block Proliferation Index, which was reduced to 1.35 ± 0.05 (P-value≤0.01) from a value of 2.08 ± 0.07 in controls. Neither TNF-a nor IFN-g was detected in the culture medium of erythroid cells treated with P. vivax, indicating that impaired erythropoiesis was independent of these cytokines. Conclusions: This study shows for the first time that P. vivax parasites inhibit erythroid development leading to ineffective erythropoiesis and highlights the potential of P. vivax to cause severe anaemia. © 2012 Panichakul et al.; licensee BioMed Central Ltd.